Criminal-law status
Is ibogaine scheduled, listed, or otherwise controlled under national criminal or drug law? A substance-control answer does not resolve medicines or facility rules.
Jurisdiction signal / evidence-first guide
Country Classification
A structured way to separate criminal control, medicine status, approval, and ordinary-patient access when reviewing where ibogaine treatment may be lawful.
Last-reviewed evidence
No clinical endorsement
Verify locally
Method / four separate questions
A legal label is not a treatment pathway
Country names are often used as shorthand for access. This guide instead keeps distinct legal systems in view, because one answer cannot reliably stand in for another.
Prescription status
Is the substance treated as a prescription medicine, or subject to another medicines-regulatory category? This can be separate from criminal scheduling.
Registration and administration
Is there an approved product or a clear lawful route for a clinic to administer it to ordinary patients? Those are distinct questions and can both remain unresolved.
Country scan / notable jurisdictions
What current public records can and cannot establish
Ibogaine is an indole alkaloid associated with the iboga plant; background descriptions should not be mistaken for a country-specific legal classification. The general ibogaine overview is useful context, while statutes and regulator records are the appropriate sources for legal conclusions.
For a broader orientation to the question of where ibogaine treatment is legal, start with the distinction between a jurisdiction’s substance rules and its actual route for clinical administration. The framework below is also designed to sit alongside the site’s explanation of how legal treatment pathways are assessed.
- Mexico and Costa Rica: frequently discussed in relation to clinic activity, but public clinic activity alone does not establish national product approval or a uniform lawful pathway. Classification: pathway requires jurisdiction-specific verification.
- New Zealand: ibogaine has been described in public materials as a prescription medicine pathway rather than a general market authorization. The Medsafe medicines classification framework is the relevant official starting point for checking current status. Classification: verify current classification and supply rules.
- Brazil, South Africa, Netherlands, Portugal, Canada, and Australia: each requires separate checking of controlled-drug law, medicine registration, import, practitioner, and facility requirements. Classification: no single regional rule.
Review sequence / evidence hierarchy
Use the same sequence for every jurisdiction
A consistent review sequence reduces the chance that an incomplete media description is treated as a legal conclusion.
Locate the rule
Check current controlled-substances schedules, medicines legislation, and regulator notices for the named jurisdiction.
Identify the category
Record whether the source actually addresses possession, prescription supply, registration, import, or administration.
Test the pathway
Look separately for a lawful ordinary-patient route, including practitioner and facility conditions where they are stated.
Mark uncertainty
When a primary source is unavailable or incomplete, state that uncertainty and preserve the last-known evidence date.
Comparison interface / cautious reading
A country matrix should not overstate what is known
These entries describe the kind of conclusion a reviewer should seek. They do not certify any provider, product, import, possession, or clinic activity as lawful.
| Jurisdiction | Criminal control | Medicine status | Approved use | Ordinary-patient pathway |
|---|---|---|---|---|
| Mexico | Verify federally | Verify regulator | Not established here | Not inferred from activity |
| New Zealand | Check current schedule | Classification to verify | Separate question | Conditions matter |
| Canada | Federal review required | Verify product status | Not assumed | Not assumed |
| Australia | Schedule review required | State and federal check | Not assumed | Not assumed |
| Brazil / South Africa / Netherlands / Portugal / Costa Rica | Jurisdiction-specific | Jurisdiction-specific | Confirm register | Confirm locally |
FAQ / interpretation boundaries
Questions that prevent false certainty
The classifications on this page are deliberately cautious. Legal status may change, and an answer to one legal question may not answer the next.
Does a country with clinics necessarily permit ibogaine?
No. Public accounts of activity, a local business registration, or a lack of a plainly available scheduling entry do not by themselves establish a lawful pathway. The four questions on this page should be checked separately.
Why can medicine status and criminal-law status differ?
Drug control, medicines regulation, professional licensing, import rules, and facility regulation can operate independently. Canada’s Controlled Drugs and Substances Act illustrates the value of consulting the governing legal framework directly rather than relying on a country label.
What does uncertainty mean in this guide?
Uncertainty means that a current primary legal source or regulator statement was not located for the specific question, or that the available materials do not establish a clear ordinary-patient pathway. It is not evidence that an activity is permitted.
Where can the methodology behind these classifications be checked?
The site’s principles for independent information explain why primary law, regulator guidance, and plainly dated evidence take priority over marketing claims or informal country lists.
Country classification is a starting point for careful verification—not a substitute for current legal advice, regulatory confirmation, or clinical assessment.
Ibogaine Legal Access · independent information resource Review country notes and resources